BR9811319A - Método para proteger um animal contra umadoença crÈnica - Google Patents

Método para proteger um animal contra umadoença crÈnica

Info

Publication number
BR9811319A
BR9811319A BR9811319-4A BR9811319A BR9811319A BR 9811319 A BR9811319 A BR 9811319A BR 9811319 A BR9811319 A BR 9811319A BR 9811319 A BR9811319 A BR 9811319A
Authority
BR
Brazil
Prior art keywords
animal
infectious organism
protect
life cycle
organism
Prior art date
Application number
BR9811319-4A
Other languages
English (en)
Inventor
Eng-Hong Lee
Original Assignee
Eng Hong Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eng Hong Lee filed Critical Eng Hong Lee
Publication of BR9811319A publication Critical patent/BR9811319A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO PARA PROTEGER UM ANIMAL CONTRA UMADOENçA CRÈNICA". A presente invenção é dirigida a um métodode proteger um animal contra uma doença crónica, a doençasendo causada por um organismo infeccioso que é submetido amais de um ciclo de vida. O método compreende: a) administrar aoanimal uma vacina contendo organismos suficientes paradesenvolver uma resposta imunológica no animal; b) manter oanimal livre de agentes quimioterapêuticos eficazes contra oorganismo infeccioso por um período de tempo correspondendo aaproximadamente um ciclo de vida do organismo; e c) administrar,posteriormente, ao animal um agente quimioterapêutico eficazcontra o organismo infeccioso por um período de tempocorrespondendo a pelo menos um ciclo de vida do organismoinfeccioso.
BR9811319-4A 1997-08-20 1998-08-20 Método para proteger um animal contra umadoença crÈnica BR9811319A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002213385A CA2213385A1 (en) 1997-08-20 1997-08-20 Method of protecting against coccidiosis infections in poultry
PCT/CA1998/000791 WO1999008704A1 (en) 1997-08-20 1998-08-20 Method of protecting against chronic infections

Publications (1)

Publication Number Publication Date
BR9811319A true BR9811319A (pt) 2001-11-20

Family

ID=4161288

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811319-4A BR9811319A (pt) 1997-08-20 1998-08-20 Método para proteger um animal contra umadoença crÈnica

Country Status (10)

Country Link
US (4) US6306385B1 (pt)
EP (1) EP1005364A1 (pt)
JP (1) JP2001515049A (pt)
CN (1) CN1272793A (pt)
AU (1) AU740407B2 (pt)
BR (1) BR9811319A (pt)
CA (1) CA2213385A1 (pt)
EA (1) EA003749B1 (pt)
IL (1) IL134627A0 (pt)
WO (1) WO1999008704A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627205B2 (en) * 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) * 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE60237977D1 (de) 2001-08-30 2010-11-25 Embrex Inc Verbesserte verfahren zur herstellung von oozysten
US7250286B2 (en) * 2002-05-21 2007-07-31 Schering-Plough Corporation Methods for the in vitro culture of Sporozoea sp. and uses thereof
CA2738682A1 (en) 2004-04-15 2005-10-15 Eng-Hong Lee Soft gel delivery system for treating poultry
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
MX2010012869A (es) * 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) * 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.
US11000580B2 (en) 2010-12-27 2021-05-11 Eng Hong Lee Roadmap for controlling malaria
EP2748300B1 (en) 2011-08-24 2018-09-19 DuPont Nutrition Biosciences ApS Enzyme producing bacillus strains
HUE059179T2 (hu) * 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US10905136B2 (en) 2015-08-14 2021-02-02 Clear H2O, Inc. High throughput process for delivering semi-firm gel for poultry
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
NZ221560A (en) 1986-08-28 1989-10-27 Lilly Co Eli Method of protecting animals against coccidiosis by the oral administration of infective coccidial organisms
US4935007A (en) 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
EP0594743B1 (en) 1991-07-12 1999-09-22 Pfizer Inc. Continuous cell line and vaccine against avian coccidia
CA2098773C (en) 1993-06-18 1999-09-21 Eng-Hong Lee Recombinant coccidia and its use in a vaccine
BR9607462A (pt) 1995-02-21 1997-12-23 Lee Eng Hong Vacina viva em forma de gel

Also Published As

Publication number Publication date
EP1005364A1 (en) 2000-06-07
US20060093627A1 (en) 2006-05-04
US20020061314A1 (en) 2002-05-23
US20050226897A1 (en) 2005-10-13
AU8848498A (en) 1999-03-08
CN1272793A (zh) 2000-11-08
EA200000152A1 (ru) 2000-10-30
EA003749B1 (ru) 2003-08-28
CA2213385A1 (en) 1999-02-20
US6306385B1 (en) 2001-10-23
IL134627A0 (en) 2001-04-30
WO1999008704A1 (en) 1999-02-25
AU740407B2 (en) 2001-11-01
JP2001515049A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
BR9811319A (pt) Método para proteger um animal contra umadoença crÈnica
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3854741D1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
RS50325B (sr) Imunostimulatorne nukleinske kiseline
BR9710740A (pt) FÄrmula de vacina polinucleotidica contra as patologias respiratÄrias e de reprodu-Æo de porcos
CO5180579A1 (es) Composicion oral solida que comprende levidopa, carbidopa y entacapone
ATE200481T1 (de) Beschränkte 9-cis-retinoide
PT1040830E (pt) Medicamento para doencas neurodegenerativas
KR960703009A (ko) 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용
ES2084390T3 (es) Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen.
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
MX9205127A (es) Una composicion farmaceutica y un metodo para usar una combinacion de un agente uricosurico y un antagonista eaa.
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
BR9609067A (pt) Composições de inibina e processos de aumentar o desempenho de produção
DE69531891D1 (de) Virus, welches die Pankreas-Krankheit bei Fischen verursacht
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
DE69928276D1 (de) Verwendung natürlicher physiologisch aktiver substanzen gegen parasitäre fischerkrankungen
MX9200428A (es) Agente preventivo contra enfermedad infecciosa de crustaceos
NL300121I2 (nl) Nieuwe bacterie die een pluimveeziekte veroorzaakten een daarvan afgeleid vaccin.
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 37, SUGIRO O INDEFERIMENTO DO PRESENTE PEDIDO TENDO POR BASE O ARTIGO 10/VIII, DA LEI 9.279 DE 14/05/96.

B12B Appeal against refusal [chapter 12.2 patent gazette]